Differential control of growth, cell cycle progression, and expression of NF-κB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the Chinese herb Rabdosia rubescens

Biochemical and Biophysical Research Communications

Volumn 337, Issue 1, 2005, Pages 224-231

  Hsieh, Tze Chen ^a   Wijeratne, E Kithsiri ^b   Liang, Jing Yu ^c   Gunatilaka, A Leslie ^b   Wu, Joseph M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Breast carcinogenesis; Cell cycle control; Induction of apoptosis; Oridonin; Ponicidin

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; DITERPENOID; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ORIDONIN; PHOSPHOPROTEIN; PLANT EXTRACT; PONICIDIN; RABDOSIA RUBESCENS EXTRACT; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN MCF 10A; CELL STRAIN MCF 7; CELL STRAIN MDA MB 231; CHINESE HERB; CLONOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABDOSIA RUBESCENS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CARCINOMA; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DITERPENES; DITERPENES, KAURANE; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; NF-KAPPA B; RABDOSIA; TUMOR STEM CELL ASSAY;

MINK CELL FOCUS-FORMING VIRUS; RABDOSIA RUBESCENS;

EID: 25844511169     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.09.040     Document Type: Article

References (40)

1. E. Marshall Epidemiology. Search for a killer: focus shifts from fat to hormones Science 259 1993 618 621
2. N.M. Perera, and G.P. Gui Multi-ethnic differences in breast cancer: current concepts and future directions Int. J. Cancer 106 2003 463 467
3. A. Jemal, A. Thomas, T. Murray, and M. Thun Cancer statistics, 2002, CA Cancer J. Clin. 52 2002 23 47
4. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Estimating the world cancer burden: Globocan 2000 Int. J. Cancer 94 2001 153 156
5. L.A. Chodosh, C.M. D'Cruz, H.P. Gardner, S.I. Ha, S.T. Marquis, J.V. Rajan, D.B. Stairs, J.Y. Wang, and M. Wang Mammary gland development, reproductive history, and breast cancer risk Cancer Res. 59 1999 1765 1771 discussion 1771s-1772s
6. R.R. Singh, and R. Kumar Steroid hormone receptor signaling in tumorigenesis J. Cell Biochem. 2005
7. G. Jasienska, I. Thune, and P.T. Ellison Energetic factors, ovarian steroids and the risk of breast cancer Eur. J. Cancer Prev. 9 2000 231 239
8. J. Bergh, P.E. Jonsson, B. Glimelius, and P. Nygren A systematic overview of chemotherapy effects in breast cancer Acta Oncol. 40 2001 253 281
9. E. Rock, and A. DeMichele Nutritional approaches to late toxicities of adjuvant chemotherapy in breast cancer survivors J. Nutr. 133 2003 3785S 3793S
10. M.M. Lee, S.S. Lin, M.R. Wrensch, S.R. Adler, and D. Eisenberg Alternative therapies used by women with breast cancer in four ethnic populations J. Natl. Cancer Inst. 92 2000 42 47
11. M.B. Sporn, and N. Suh Chemoprevention: an essential approach to controlling cancer Nat. Rev. Cancer 2 2002 537 543
12. M.B. Sporn, and N. Suh Chemoprevention of cancer Carcinogenesis 21 2000 525 530
13. A. Decensi, and A. Costa Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer Eur. J. Cancer 36 2000 694 709
14. Z. Darzynkiewicz, F. Traganos, J.M. Wu, and S. Chen Chinese herbal mixture PC SPES in treatment of prostate cancer (review) Int. J. Oncol. 17 2000 729 736
15. H.D. Halicka, B. Ardelt, G. Juan, A. Mittleman, S. Chen, F. Traganos, and Z. Darzynkiewicz Apoptosis and cell cycle effects induced by extracts of the Chinese herbal preparation PC SPES Int. J. Oncol. 11 1997 437 448
16. L.C. Meade-Tollin, E.M. Wijeratne, D. Cooper, M. Guild, E. Jon, A. Fritz, G.X. Zhou, L. Whitesell, J.Y. Liang, and A.A. Gunatilaka Ponicidin and oridonin are responsible for the antiangiogenic activity of Rabdosia rubescens, a constituent of the herbal supplement PC SPES J. Nat. Prod. 67 2004 2 4
17. M.R. Sartippour, N.P. Seeram, D. Heber, M. Hardy, A. Norris, Q. Lu, L. Zhang, M. Lu, J.Y. Rao, and M.N. Brooks Rabdosia rubescens inhibits breast cancer growth and angiogenesis Int. J. Oncol. 26 2005 121 127
18. T.C. Hsieh, P. Burfeind, K. Laud, J.M. Backer, F. Traganos, Z. Darzynkiewicz, and J.M. Wu Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials Int. J. Oncol. 15 1999 245 252
19. T.C. Hsieh, Z. Wang, C.V. Hamby, and J.M. Wu Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53 Biochem. Biophys. Res. Commun. 334 2005 223 230
20. T.C. Hsieh, X. Lu, J. Guo, W. Xiong, J. Kunicki, Z. Darzynkiewicz, and J.M. Wu Effects of herbal preparation Equiguard on hormone-responsive and hormone-refractory prostate carcinoma cells: mechanistic studies Int. J. Oncol. 20 2002 681 689
21. Y. Fu, T.C. Hsieh, J. Guo, J. Kunicki, M.Y. Lee, Z. Darzynkiewicz, and J.M. Wu Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells Biochem. Biophys. Res. Commun. 322 2004 263 270
22. T.C. Hsieh, G. Juan, Z. Darzynkiewicz, and J.M. Wu Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2 Cancer Res. 59 1999 2596 2601
23. A.M. DiPietrantonio, T.C. Hsieh, S.C. Olson, and J.M. Wu Regulation of G1/S transition and induction of apoptosis in HL-60 leukemia cells by fenretinide (4HPR) Int. J. Cancer 78 1998 53 61
24. F. Koudssi, J.E. Lopez, S. Villegas, and C.S. Long Cardiac fibroblasts arrest at the G1/S restriction point in response to interleukin (IL)-1beta. Evidence for IL-1beta-induced hypophosphorylation of the retinoblastoma protein J. Biol. Chem. 273 1998 25796 25803
25. S.Y. Tsai, B. Ardelt, T.C. Hsieh, Z. Darzynkiewicz, K. Shogen, and J.M. Wu Treatment of Jurkat acute T-lymphocytic leukemia cells by onconase (Ranpirnase) is accompanied by an altered nucleocytoplasmic distribution and reduced expression of transcription factor NF-kappaB Int. J. Oncol. 25 2004 1745 1752
26. P.A. Baeuerle, and D. Baltimore NF-kappa B: ten years after Cell 87 1996 13 20
27. C.H. Leung, S.P. Grill, W. Lam, Q.B. Han, H.D. Sun, and Y.C. Cheng Novel mechanism of inhibition of nuclear factor-kappaB DNA-binding activity by diterpenoids isolated from Isodon rubescens Mol. Pharmacol. 68 2005 286 297
28. H.M. Liu, X. Yan, F. Kiuchi, and Z. Liu A new diterpene glycoside from Rabdosia rubescens Chem. Pharm. Bull. (Tokyo) 48 2000 148 149
29. Z.G. Gao, Q.X. Ye, and T.M. Zhang Synergistic effect of oridonin and cisplatin on cytotoxicity and DNA cross-link against mouse sarcoma S180 cells in culture Zhongguo Yao Li Xue Bao 14 1993 561 564
30. T. Ikezoe, S.S. Chen, X.J. Tong, D. Heber, H. Taguchi, and H.P. Koeffler Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells Int. J. Oncol. 23 2003 1187 1193
31. T. Ikezoe, Y. Yang, K. Bandobashi, T. Saito, S. Takemoto, H. Machida, K. Togitani, H.P. Koeffler, and H. Taguchi Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways Mol. Cancer Ther. 4 2005 578 586
32. S. Chen, J. Gao, H.D. Halicka, X. Huang, F. Traganos, and Z. Darzynkiewicz The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage Int. J. Oncol. 26 2005 579 588
33. C.L. Zhang, L.J. Wu, S. Tashiro, S. Onodera, and T. Ikejima Oridonin induces apoptosis of HeLa cells via altering expression of Bcl-2/Bax and activating caspase-3/ICAD pathway Acta Pharmacol. Sin. 25 2004 691 698
34. C.L. Zhang, L.J. Wu, S. Tashiro, S. Onodera, and T. Ikejima Oridonin induces a caspase-independent but mitochondria- and MAPK-dependent cell death in the murine fibrosarcoma cell line L929 Biol. Pharm. Bull. 27 2004 1527 1531
35. C.L. Zhang, L.J. Wu, H.J. Zuo, S. Tashiro, S. Onodera, and T. Ikejima Cytochrome c release from oridonin-treated apoptotic A375-S2 cells is dependent on p53 and extracellular signal-regulated kinase activation J. Pharmacol. Sci. 96 2004 155 163
36. J. Liu, R. Huang, D. Lin, X. Wu, J. Peng, Q. Lin, X. Pan, M. Zhang, M. Hou, and F. Chen Apoptotic effect of oridonin on NB4 cells and its mechanism Leuk. Lymphoma 46 2005 593 597
37. Y.Q. Liu, S. You, C.L. Zhang, S. Tashiro, S. Onodera, and T. Ikejima Oridonin enhances phagocytosis of UV-irradiated apoptotic U937 cells Biol. Pharm. Bull. 28 2005 461 467
38. Y.Q. Liu, S. You, S.I. Tashiro, S. Onodera, and T. Ikejima Activation of phosphoinositide 3-kinase, protein kinase C, and extracellular signal-regulated kinase is required for oridonin-enhanced phagocytosis of apoptotic bodies in human macrophage-like U937 cells J. Pharmacol. Sci. 2005
39. F.G. Berger The interleukin-6 gene: a susceptibility factor that may contribute to racial and ethnic disparities in breast cancer mortality Breast Cancer Res. Treat. 88 2004 281 285
40. S.A. Schwartz, A. Hernandez, and B. Mark Evers The role of NF-kappaB/IkappaB proteins in cancer: implications for novel treatment strategies Surg. Oncol. 8 1999 143 153